Tackling Emerging Post-COVID Autoimmune Trends: In-depth CTD-ILD Market Database
26. Oktober 2023 12:33 ET
|
Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- In a significant development reported this month in JAMA Network Open, South Korean researchers have pointed out an increased risk of various new-onset...
Global Idiopathic Pulmonary Fibrosis (IPF) Market to 2029: Players Include Boehringer Ingelheim, F. Hoffmann-La Roche, Cipla and Shionogi & Co
13. Juli 2023 04:33 ET
|
Research and Markets
Dublin, July 13, 2023 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis (IPF) Market (2023 Edition): Analysis By Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration...
Global Idiopathic Pulmonary Fibrosis Market Report 2023: Sector is Expected to Reach $7.52 Billion by 2030 at a CAGR of 8.7%
15. Juni 2023 08:03 ET
|
Research and Markets
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Market, By Drug, By Route of Administration, By Distribution Channel, and By Geography - Size, Share, Outlook, and...
Idiopathic Pulmonary Fibrosis Market to Surpass US$ 7,521.2 Million by 2030, Says Coherent Market Insights (CMI)
25. Mai 2023 09:01 ET
|
CMI
Burlingame, May 25, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global idiopathic pulmonary fibrosis market is estimated to be valued at US$ 3,853.6 million in 2022 and is...
Europe Idiopathic Pulmonary Fibrosis Market Report 2022: Featuring Key Players GNI Group, Shionogi & Co, AstraZeneca & Others
11. August 2022 05:03 ET
|
Research and Markets
Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "Europe Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies,...
LAMEA Idiopathic Pulmonary Fibrosis Market Report 2022: Featuring Key Players GNI Group, AstraZeneca, Bristol Myers Squibb & Others
04. August 2022 04:38 ET
|
Research and Markets
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "LAMEA Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies,...
APAC Idiopathic Pulmonary Fibrosis Market to 2027 - Size, Share & Industry Trends Analysis Report
19. Mai 2022 05:03 ET
|
Research and Markets
Dublin, May 19, 2022 (GLOBE NEWSWIRE) -- The "Asia Pacific Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail...
The Worldwide Idiopathic Pulmonary Fibrosis Industry is Expected to Reach $4.7 Billion by 2027
25. April 2022 07:08 ET
|
Research and Markets
Dublin, April 25, 2022 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail...
The Worldwide Idiopathic Pulmonary Fibrosis Industry is Projected to Reach $6 Billion by 2030
31. März 2022 06:13 ET
|
Research and Markets
Dublin, March 31, 2022 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Market by Drug Type and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has...
Global Idiopathic Pulmonary Fibrosis (IPF) Industry Forecast, 2030 - Competitive Landscape Assessment, Product Development & Innovation, Case Reports, Marketed Products & Emerging Therapies
28. Februar 2022 06:23 ET
|
Research and Markets
Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis Market, By Therapy, Estimation & Forecast, 2017-2030" report has been added to ResearchAndMarkets.com's...